AYTU BIOSCIENCE, INC License Agreements
9 Contracts & Agreements
- Exclusive License Agreement between Rumpus VEDS, LLC and Johns Hopkins University, dated December 20, 2019 (Filed With SEC on May 17, 2021)
- Option and Exclusive License Agreement between Rumpus VEDS, LLC and Denovo Biopharma LLC, dated December 21, 2019 (Filed With SEC on May 17, 2021)
- License Agreement with Avrio Genetics, LLC, dated January 20, 2020 (Filed With SEC on February 11, 2021)
- Waiver and Amendment to the July 29, 2019 Amended and Restated License and Supply Agreement (Filed With SEC on December 2, 2019)
- AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT BETWEEN ACERUS PHARMACEUTICALS CORPORATION and AYTU BIOSCIENCE, INC. Dated as of July 29, 2019 (Filed With SEC on August 2, 2019)
- License, Development, Manufacturing and Supply Agreement dated November 2, 2018 between Aytu BioScience, Inc. and TRIS Pharma, Inc (Filed With SEC on February 7, 2019)
- Amended and Restated Exclusive License Agreement, dated June 11, 2018, between Aytu BioScience, Inc. and Magna Pharmaceuticals, Inc (Filed With SEC on September 6, 2018)
- License, Development and Commercialization Agreement between the Registrant (as assigned to it by Ampio/Vyrix) and Daewoong Pharmaceuticals Co., Ltd., effective as of August 23,... (Filed With SEC on September 6, 2018)
- LICENSE AND SUPPLY AGREEMENT BETWEEN ACERUS PHARMACEUTICALS SRL and AYTU BIOSCIENCE, INC. (Filed With SEC on April 25, 2016)
